Summary: Researchers have created a computational framework that explains how the striosomal compartment of the striatum shapes everyday decision-making. By combining biological data, decision theory, and mathematical modeling, the study shows that different levels of striosomal activity bias people toward impulsive, balanced, or overly deliberative choices. High striosomal activity steers decisions toward quick, reward-driven options, while low activity leads to slower, more complex deliberation. These insights offer a new perspective on impaired decision-making in psychiatric disorders and suggest that targeting striosomal activity could become a therapeutic avenue.
The work, led by scientists at the Icahn School of Medicine at Mount Sinai in collaboration with the University of Texas at El Paso, presents a model that maps how information flows into the striosomes and how striosomal circuits select which features are used to evaluate options. The model links circuit dynamics to observable decision behavior and provides a framework for understanding how altered striosomal function may contribute to symptoms across different neuropsychiatric conditions.
Key Facts:
- Activity spectrum: Varying levels of striosomal activity determine whether decisions are simple and fast, balanced, complex, or delayed.
- Psychiatric relevance: Abnormal striosomal function is implicated in decision-making deficits seen in conditions such as post-traumatic stress disorder (PTSD), substance use disorders, and depression.
- Therapeutic potential: Modulating striosomal activity may offer a novel strategy for treating decision-making impairments in psychiatric disorders.
Source: Mount Sinai Hospital
Study overview
The striatum is a central brain structure that integrates motivation, reward, motor planning, and aspects of cognition to support goal-directed behavior. Anatomically and neurochemically, the striatum consists of intermingled compartments known as striosomes and matrix. Despite extensive evidence that the striatum contributes to cost-benefit decision-making, the specific role of the striosomal compartment has been unclear.
To address this gap, the research team developed a decision-space computational model that captures how the striosomes construct a context-dependent mathematical representation of the decision environment. The matrix compartment then evaluates actions within that constructed space to assign value to available choices. By integrating experimental findings and established theories such as reward prediction error and direct versus indirect pathway roles, the model unifies multiple lines of evidence under a single explanatory framework.
The model indicates that the striosomes act as a filter: incoming signals about potentially relevant decision factors are evaluated there, and the striosomal activity level determines how many and which factors are forwarded for action evaluation. When striosomal activity is elevated, decision-making tends to be simplified—often focused on a single dominant factor such as expected reward. At very high activity levels, this simplification becomes pathological, producing impulsive choices that favor reward while discounting potential costs.
Conversely, lower striosomal activity allows more factors to contribute to the decision process, producing more complex and deliberative choices. If activity falls too low, however, the system can become overloaded by excessive dimensionality: too many variables are considered and neural circuits fail to converge, resulting in prolonged indecision or “analysis paralysis.”
Clinical implications
The framework offers a concrete mechanism linking circuit-level dynamics to behavioral symptoms seen across psychiatric conditions. For example, disorders characterized by risk-seeking or impulsive behavior—such as certain presentations of PTSD or substance use disorders—may reflect abnormally high striosomal activity that biases decisions toward immediate reward and away from cost consideration. In contrast, conditions marked by pervasive indecision and reduced motivation, such as major depressive disorder, could reflect insufficient striosomal activity and excessive consideration of many competing factors.
Beyond explaining symptom profiles, the model raises the possibility that therapeutic modulation of striosomal activity—through pharmacological, neuromodulatory, or behavioral interventions—could rebalance decision computations and improve functional outcomes. The authors emphasize the need for further empirical work to map how striosomal activity changes across disorders and to test targeted interventions guided by the model’s predictions.
This research was a collaborative effort involving the Friedman Brain Institute, the Center for Translational Medicine and Pharmacology, and the Departments of Psychiatry and Pharmacological Sciences at Mount Sinai and the University of Texas at El Paso.
About this neuroscience research news
Author: Elizabeth Dowling
Source: Mount Sinai Hospital
Contact: Elizabeth Dowling – Mount Sinai Hospital
Image credit: Neuroscience News
Original Research: Open access. “A decision-space model explains context-specific decision-making” by Ki Goosens et al., published in Nature Communications.
Abstract
A decision-space model explains context-specific decision-making
Optimal decision-making depends on weighting internal and external contexts appropriately. Biased decision-making appears across many neuropsychiatric disorders. The authors present a computational model showing how striosomes create a context-dependent decision space and how the matrix assigns action values within that space. The model reconciles several experimental findings and theoretical accounts—such as reward prediction error and the roles of direct versus indirect pathways—into a unified framework. New analyses also show increased synchrony of striosome and matrix neurons during difficult tasks, reflecting a necessary increase in dimensionality of the decision space. The model yields testable predictions about individual susceptibility to disorders, shared decision-making symptoms across diagnoses, and variability in symptom expression, supporting a central role for striosomes in neuroeconomic and disorder-affected decision-making.